CalciMedica may offer up to $25M in common stock
The prospectus supplement is under a Form S-3 shelf registration statement declared effective March 11, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
8-K
Rhea-AI Filing Summary
CalciMedica, Inc. (CALC) may offer and sell common stock with an aggregate offering price of up to $25,000,000 from time to time under its at-the-market offering agreement with H.C. Wainwright & Co., dated August 11, 2023.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Maximum aggregate offering price: Up to $25,000,000
Common stock par value: $0.0001 per share
At-the-market offering agreement date: August 11, 2023
+2 more
5 metrics
Maximum aggregate offering price
Up to $25,000,000
Common stock offered from time to time under the at-the-market offering agreement.
Common stock par value
$0.0001 per share
Common stock covered by the prospectus supplement.
At-the-market offering agreement date
August 11, 2023
Agreement with H.C. Wainwright & Co.
Form S-3 shelf registration statement filed
March 3, 2026
Initial filing date stated for the shelf registration statement.
Form S-3 shelf registration statement effective
March 11, 2026
Effective date stated for the shelf registration statement.
Key Terms
at-the-market offering agreement, aggregate offering price, shelf registration statement, prospectus supplement
4 terms
at-the-market offering agreement financial
"under the Company’s at-the-market offering agreement"
An at-the-market offering agreement lets a public company sell newly issued shares into the open market over time at the current trading price through an appointed broker, rather than all at once. Investors care because it provides the company flexible access to cash but can slowly reduce each existing shareholder’s ownership and put downward pressure on the stock price—like a shop owner quietly adding items for sale to a crowded shelf.
aggregate offering price financial
"having an aggregate offering price of up to $25,000,000"
The aggregate offering price is the total dollar amount that will be raised if all the securities in an offering are sold at the stated offering price, before fees or expenses are taken out. Investors use it to gauge the size of the fundraising and its potential effects—such as how much cash the company will get and how much existing ownership might be reduced—similar to totaling every item’s price in a shopping cart to see the full bill.
shelf registration statement regulatory
"under the Company’s shelf registration statement on Form S-3"
A shelf registration statement is a document a company files with regulators that allows it to sell shares or bonds quickly when it’s a good time to raise money. It’s like having a pre-approved plan ready so the company can act fast without going through lengthy paperwork each time they want to sell, making fundraising more flexible.
prospectus supplement regulatory
"filed a prospectus supplement"
A prospectus supplement is an additional document provided alongside a company's main offering details, offering updated or extra information about a specific financial product being sold. It helps investors understand the latest terms, risks, and details of the investment, similar to how an update or revision clarifies or expands on original instructions, ensuring they have current and complete information before making a decision.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How much common stock may CALC sell through its at-the-market offering?
CalciMedica may offer and sell common stock with an aggregate offering price of up to $25,000,000 under its at-the-market offering agreement. Sales may occur from time to time.
AI-generated analysis. How Rhea-AI works. Not financial advice.
